Page last updated: 2024-09-03

n-(2-(dimethylamino)ethyl)-n-methyl-4-(2,3,6,7-tetrahydro-2,6-dioxo-1,3-dipropyl-1h-purin-8-yl)benzenesulfonamide and Coronary Disease

n-(2-(dimethylamino)ethyl)-n-methyl-4-(2,3,6,7-tetrahydro-2,6-dioxo-1,3-dipropyl-1h-purin-8-yl)benzenesulfonamide has been researched along with Coronary Disease in 2 studies

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's2 (100.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Downey, JM; Thornton, CS; Thornton, JD1
Auchampach, JA; Gross, GJ1

Other Studies

2 other study(ies) available for n-(2-(dimethylamino)ethyl)-n-methyl-4-(2,3,6,7-tetrahydro-2,6-dioxo-1,3-dipropyl-1h-purin-8-yl)benzenesulfonamide and Coronary Disease

ArticleYear
Effect of adenosine receptor blockade: preventing protective preconditioning depends on time of initiation.
    The American journal of physiology, 1993, Volume: 265, Issue:2 Pt 2

    Topics: Adaptation, Physiological; Animals; Coronary Disease; Female; Male; Myocardial Infarction; Purinergic Antagonists; Purines; Rabbits; Recurrence; Sulfonamides; Time Factors

1993
Adenosine A1 receptors, KATP channels, and ischemic preconditioning in dogs.
    The American journal of physiology, 1993, Volume: 264, Issue:5 Pt 2

    Topics: Adenosine; Adenosine Triphosphate; Animals; Blood Glucose; Coronary Circulation; Coronary Disease; Dogs; Female; Glyburide; Hemodynamics; Male; Myocardial Infarction; Myocardial Reperfusion; Potassium Channels; Purines; Receptors, Purinergic; Sulfonamides; Xanthines

1993